Andrew Cheng - Nov 12, 2025 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
President and CEO, Director
Signature
/s/ Jonathan Young, Attorney-in-Fact
Stock symbol
AKRO
Transactions as of
Nov 12, 2025
Transactions value $
$0
Form type
4
Date filed
11/13/2025, 08:03 PM
Previous filing
Oct 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cheng Andrew President and CEO, Director C/O AKERO THERAPEUTICS, INC., 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO /s/ Jonathan Young, Attorney-in-Fact 2025-11-13 0001778307

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Gift $0 -14.7K -2.8% $0.00 511K Nov 12, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction represents a bona fide charitable gift to a 501(c)(3) organization. The Reporting Person does not have any pecuniary interest in the 501(c)(3) organization.